Apeloa Pharmaceutical Co. Ltd. A | Cash Flow
Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
160,985.70
326,717.10
208,230.30
262,897.10
256,592.10
370,566.80
Depreciation, Depletion & Amortization
227,571.80
247,870.10
286,748.10
302,557.60
332,738.00
330,458.90
Other Funds
264,042.60
128,874.20
100.00
110,400.00
258,326.90
49,683.60
Funds from Operations
483,419.20
586,245.70
502,578.80
539,870.50
643,267.60
762,372.80
Changes in Working Capital
292,973.70
200,392.00
126,482.10
425,769.40
495,148.30
29,068.80
Net Operating Cash Flow
190,445.50
786,637.60
376,096.80
114,101.10
148,119.40
791,441.60
Capital Expenditures
505,005.30
540,218.60
452,064.60
331,353.20
163,423.50
Sale of Fixed Assets & Businesses
9,929.40
137,602.20
23,185.10
36,508.60
83,254.70
Purchase/Sale of Investments
8,436.80
38.20
690.30
202.50
-
Net Investing Cash Flow
504,131.20
471,645.70
526,543.80
299,763.70
80,168.90
Cash Dividends Paid - Total
-
8,154.60
97,483.90
63,077.80
79,134.00
Issuance/Reduction of Debt, Net
113,164.60
444,565.40
298,884.20
66,327.20
207,431.80
Net Financing Cash Flow
377,207.20
323,845.70
201,500.30
113,649.40
30,120.60
Net Change in Cash
63,521.50
9,586.60
61,159.30
53,635.30
23,420.40
Free Cash Flow
314,559.70
246,419.00
75,967.80
217,252.10
15,304.10
Deferred Taxes & Investment Tax Credit
383.10
7,745.90
18,290.80
7,711.90
12,572.20
11,663.50
Net Assets from Acquisitions
1,606.90
79,824.50
85,420.00
-
-
Other Sources
988.40
10,987.50
5,000.00
498.80
-
Change in Capital Stock
-
-
-
-
1,881.70
Exchange Rate Effect
-
732.90
10,106.00
18,377.90
14,409.60
Other Uses
-
230.40
16,554.10
5,620.40
-
About Apeloa Pharmaceutical Co.
View Profile
